154 related articles for article (PubMed ID: 31676217)
21. DUAAL: atorvastatin provided an unexpectedly potent heart benefit in patients with chronic stable angina.
Cardiovasc J Afr; 2008; 19(3):174. PubMed ID: 18568187
[No Abstract] [Full Text] [Related]
22. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
[TBL] [Abstract][Full Text] [Related]
23. Interpreting the COURAGE trial. It takes COURAGE to alter our belief system.
Boden WE
Cleve Clin J Med; 2007 Sep; 74(9):623-5, 629-33. PubMed ID: 17879516
[No Abstract] [Full Text] [Related]
24. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.
Aziz O; Rao C; Panesar SS; Jones C; Morris S; Darzi A; Athanasiou T
BMJ; 2007 Mar; 334(7594):617. PubMed ID: 17337458
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
[TBL] [Abstract][Full Text] [Related]
27. Inappropriate inclusion of multiple studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome.
Turgeon RD; Althouse AD
Eur Heart J; 2019 Mar; 40(11):941-942. PubMed ID: 30783662
[No Abstract] [Full Text] [Related]
28. Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data
.
Sun YY; Liu LY; Sun T; Wu MY; Ma FZ
Clin Nephrol; 2019 Sep; 92(3):123-130. PubMed ID: 31347493
[TBL] [Abstract][Full Text] [Related]
29. The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizons.
di Sciascio G
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():41-3. PubMed ID: 18001321
[TBL] [Abstract][Full Text] [Related]
30. Lack of evidence-based practice leads to major geographical variations in elective coronary revascularization by stents or surgery in England.
Carrel T
Eur J Cardiothorac Surg; 2015 May; 47(5):860-1. PubMed ID: 25149107
[No Abstract] [Full Text] [Related]
31. [Percutaneous coronary intervention in stable coronary artery disease].
Piróth Z
Orv Hetil; 2014 Dec; 155(49):1952-9. PubMed ID: 25434515
[TBL] [Abstract][Full Text] [Related]
32. Inclusion of multiple inappropriate studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome: editor's response.
Lüscher TF; Davies A
Eur Heart J; 2019 Mar; 40(11):943. PubMed ID: 30783647
[No Abstract] [Full Text] [Related]
33. Quantitative assessment of tissue prolapse on optical coherence tomography and its relation to underlying plaque morphologies and clinical outcome in patients with elective stent implantation.
Sugiyama T; Kimura S; Akiyama D; Hishikari K; Kawaguchi N; Kamiishi T; Hikita H; Takahashi A; Isobe M
Int J Cardiol; 2014 Sep; 176(1):182-90. PubMed ID: 25042663
[TBL] [Abstract][Full Text] [Related]
34. Vitamin C and percutaneous coronary intervention: some answers, more questions.
Gebhard C; Tardif JC
Can J Cardiol; 2014 Jan; 30(1):3-5. PubMed ID: 24365188
[No Abstract] [Full Text] [Related]
35. Who does not need a statin: too late in end-stage renal disease or heart failure?
Laufs U; Custodis F; Böhm M
Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
[TBL] [Abstract][Full Text] [Related]
36. Coronary artery bypass graft surgery remains the standard of care for patients with diabetes.
Moss E; Alam M; Ballantyne CM; Puskas JD
Semin Thorac Cardiovasc Surg; 2013; 25(2):97-9. PubMed ID: 24216525
[TBL] [Abstract][Full Text] [Related]
37. Outcome of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: A single-center experience.
Tomasello SD; Boukhris M; Ganyukov V; Galassi AR; Shukevich D; Haes B; Kochergin N; Tarasov R; Popov V; Barbarash L
Heart Lung; 2015; 44(4):309-13. PubMed ID: 25913808
[TBL] [Abstract][Full Text] [Related]
38. Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
Mehta V; Sukhija R; Mehra P; Goyal A; Yusuf J; Mahajan B; Gupta VK; Tyagi S; Palaniswamy C; Aronow WS
Indian Heart J; 2016; 68(1):57-62. PubMed ID: 26896268
[TBL] [Abstract][Full Text] [Related]
39. Remote ischemic preconditioning reduces peri-procedural myocardial injury in elective percutaneous coronary intervention: a meta-analysis.
Zografos TA; Katritsis GD; Katritsis DG
Int J Cardiol; 2014 May; 173(3):530-2. PubMed ID: 24681008
[No Abstract] [Full Text] [Related]
40. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
